Standout Papers

Global strategy for asthma management and prevention: GINA executi... 1999 2026 2008 2017 2.3k
  1. Global strategy for asthma management and prevention: GINA executive summary (2007)
    Eric D. Bateman, Suzanne S. Hurd et al. European Respiratory Journal
  2. Asthma phenotypes: the evolution from clinical to molecular approaches (2012)
    Sally E. Wenzel Nature Medicine
  3. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma (2014)
    Elisabeth H. Bel, Sally E. Wenzel et al. New England Journal of Medicine
  4. Dupilumab in Persistent Asthma with Elevated Eosinophil Levels (2013)
    Sally E. Wenzel, Linda Ford et al. New England Journal of Medicine
  5. Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics (1999)
    Sally E. Wenzel, Lawrence B. Schwartz et al. American Journal of Respiratory and Critical Care Medicine
  6. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome (2011)
    Jan Lötvall, Cezmi A. Akdiş et al. Journal of Allergy and Clinical Immunology
  7. Asthma: defining of the persistent adult phenotypes (2006)
    Sally E. Wenzel The Lancet
  8. Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma (2017)
    Parameswaran Nair, Sally E. Wenzel et al. New England Journal of Medicine
  9. Exploring the Effects of Omalizumab in Allergic Asthma (2013)
    Nicola A. Hanania, Sally E. Wenzel et al. American Journal of Respiratory and Critical Care Medicine
  10. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial (2016)
    Sally E. Wenzel, Mario Castro et al. The Lancet
  11. Bronchoscopic Evaluation of Severe Asthma (1997)
    Sally E. Wenzel, Stanley J. Szefler et al. American Journal of Respiratory and Critical Care Medicine
  12. A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma (2007)
    Patrick Flood-Page, Cheri A. Swenson et al. American Journal of Respiratory and Critical Care Medicine
  13. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis (2013)
    Wendy C. Moore, Annette T. Hastie et al. Journal of Allergy and Clinical Immunology
  14. Asthma (2015)
    Stephen T. Holgate, Sally E. Wenzel et al. Nature Reviews Disease Primers
  15. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study (2015)
    David Price, Anna Rigazio et al. The Lancet Respiratory Medicine
  16. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia (2013)
    Michel Laviolette, David Gossage et al. Journal of Allergy and Clinical Immunology
  17. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts (2016)
    Michael C. Peters, Kevin McGrath et al. The Lancet Respiratory Medicine
  18. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study (2014)
    Mario Castro, Sally E. Wenzel et al. The Lancet Respiratory Medicine
  19. Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial (2021)
    Sarah Diver, Latifa Khalfaoui et al. The Lancet Respiratory Medicine

Immediate Impact

3 by Nobel laureates 8 from Science/Nature 111 standout
Sub-graph 1 of 16

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Principles and therapeutic applications of adaptive immunity
2024 Standout

Works of Sally E. Wenzel being referenced

Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
2013 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout

Author Peers

Author Last Decade Papers Cites
Sally E. Wenzel 26889 18317 9120 328 33.8k
Paul M. O’Byrne 29721 22141 6472 510 37.1k
William W. Busse 25643 16406 8084 520 33.6k
Christopher E. Brightling 20456 16720 6789 405 28.0k
Andrew J. Wardlaw 19199 12320 8190 252 26.6k
Pascal Chanez 18206 14143 5069 408 24.8k
Ian Pavord 27308 23603 5857 501 33.7k
Qutayba Hamid 22365 10000 12257 496 36.9k
Eugene R. Bleecker 19159 14246 4916 293 24.4k
Dirkje S. Postma 16257 18310 3468 564 30.4k
Guy Brusselle 11692 11972 4182 389 21.9k

All Works

Loading papers...

Rankless by CCL
2026